MELILLO, ROSA MARINA
MELILLO, ROSA MARINA
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents
2024 Caggiano, Rocco; Prokhorova, Evgeniia; Duma, Lena; Schützenhofer, Kira; Lauro, Raffaella; Catara, Giuliana; Melillo, Rosa Marina; Celetti, Angela; Smith, Rebecca; Weroha, S John; Kaufmann, Scott H; Ahel, Ivan; Palazzo, Luca
Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer
2024 Maietta, Immacolata; Viscusi, Eleonora; Laudati, Stefano; Iannaci, Giuseppe; D'Antonio, Antonio; Melillo, ROSA MARINA; Letizia Motti, Maria; DE FALCO, Valentina
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness
2023 De Martino, Marco; Pellecchia, Simona; Esposito, Francesco; Liotti, Federica; Credendino, Sara Carmela; Prevete, Nella; Decaussin-Petrucci, Myriam; Chieffi, Paolo; De Vita, Gabriella; Melillo, Rosa Marina; Fusco, Alfredo; Pallante, Pierlorenzo
Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines
2022 Ambrosio, M. R.; Mosca, G.; Migliaccio, T.; Liguoro, D.; Nele, G.; Schonauer, F.; D'Andrea, F.; Liotti, F.; Prevete, N.; Melillo, R. M.; Reale, C.; Ambrosino, C.; Miele, C.; Beguinot, F.; D'Esposito, V.; Formisano, P.
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma
2022 Morra, Francesco; Merolla, Francesco; Damia, Giovanna; Ricci, Francesca; Varricchio, Silvia; Ilardi, Gennaro; Arenare, Laura; Califano, Daniela; Napolitano, Virginia; Fruscio, Robert; Melillo, Rosa Marina; Palazzo, Luca; Celetti, Angela
AXL is a novel predictive factor and therapeutic target for radioactive iodine refractory thyroid cancer
2019 Collina, F; La Sala, L; Liotti, F; Prevete, N; La Mantia, E; Chiofalo, Mg; Aquino, G; Arenare, L; Cantile, M; Liguori, G; Di Gennaro, F; Pezzullo, L; Losito, Ns; Vecchio, G; Botti, G; Melillo, Rm; Franco, R
Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies
2019 Liotti, Federica; Prevete, Nella; Vecchio, Giancarlo; Melillo, Rosa Marina
New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution
2018 Prevete, Nella; Prevete, Nella; Liotti, Federica; Amoresano, Angela; Pucci, Piero; de Paulis, Amato; Melillo, ROSA MARINA; Melillo, ROSA MARINA
RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2).
2018 Castellone, Md; Melillo, Rm
Role of Formyl Peptide Receptors In Gastrointestinal Healing.
2018 Prevete, N; de Paulis, A; Sgambato, D; Melillo, Rm; D'Argenio, G; Romano, L; Zagari, Rm; Romano, M
Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways
2017 Prevete, Nella; Liotti, Federica; Illiano, Anna; Amoresano, Angela; Pucci, Piero; de Paulis, Amato; Melillo, Rosa Marina
Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells
2017 Liotti, Federica; Collina, Francesca; Pone, Emanuela; La Sala, Lucia; Franco, Renato; Prevete, Nella; Melillo, ROSA MARINA
Multiple anti-tumor effects of Reparixin on thyroid cancer
2017 Liotti, Federica; De Pizzol, Maria; Allegretti, Marcello; Prevete, Nella; Melillo, Rosa Marina
AXL is an oncotarget in human colorectal cancer
2015 Martinelli, Erika; Martini, Giulia; Cardone, Claudia; Troiani, Teresa; Liguori, Giuseppina; Vitagliano, Donata; Napolitano, Stefania; Morgillo, Floriana; Rinaldi, Barbara; Melillo, ROSA MARINA; Liotti, Federica; Nappi, Anna; Bianco, Roberto; Berrino, Liberato; Ciuffreda Loreta, Pia; Ciardiello, Davide; Iaffaioli, Vincenzo; Botti, Gerardo; Ferraiolo, Fiorella; Ciardiello, Fortunato
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth
2015 Prevete, Nella; Liotti, Federica; Marone, Gianni; Melillo, Rosa Marina; De Paulis, Amato
Genetics: The genomic landscape of papillary thyroid carcinoma
2015 Santoro, Massimo; Melillo Rosa, M
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.
2015 Visciano, C; Liotti, F; Prevete, N; Cali', G; Franco, R; Collina, F; de Paulis, A; Marone, G; Santoro, M; Melillo, Rm
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis
2015 Prevete, N; Liotti, F; Visciano, C; Marone, G; Melillo, Rm; De Paulis, A
The RET receptor family
2015 Melillo, ROSA MARINA; Santoro, Massimo
Indoleamine 2,3-Dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment
2014 Moretti S.; Menicali E.; Voce P.; Morelli S.; Cantarelli S.; Sponziello M.; Colella R.; Fallarino F.; Orabona C.; Alunno A.; De Biase D.; Bini V.; Mameli M.G.; Filetti S.; Gerli R.; Macchiarulo A.; Melillo R.M.; Tallini G.; Santoro M.; Puccetti P.; Avenia N.; Puxeddu E.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents | 1-gen-2024 | Caggiano, Rocco; Prokhorova, Evgeniia; Duma, Lena; Schützenhofer, Kira; Lauro, Raffaella; Catara, Giuliana; Melillo, Rosa Marina; Celetti, Angela; Smith, Rebecca; Weroha, S John; Kaufmann, Scott H; Ahel, Ivan; Palazzo, Luca | |
Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer | 1-gen-2024 | Maietta, Immacolata; Viscusi, Eleonora; Laudati, Stefano; Iannaci, Giuseppe; D'Antonio, Antonio; Melillo, ROSA MARINA; Letizia Motti, Maria; DE FALCO, Valentina | |
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness | 1-gen-2023 | De Martino, Marco; Pellecchia, Simona; Esposito, Francesco; Liotti, Federica; Credendino, Sara Carmela; Prevete, Nella; Decaussin-Petrucci, Myriam; Chieffi, Paolo; De Vita, Gabriella; Melillo, Rosa Marina; Fusco, Alfredo; Pallante, Pierlorenzo | |
Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines | 1-gen-2022 | Ambrosio, M. R.; Mosca, G.; Migliaccio, T.; Liguoro, D.; Nele, G.; Schonauer, F.; D'Andrea, F.; Liotti, F.; Prevete, N.; Melillo, R. M.; Reale, C.; Ambrosino, C.; Miele, C.; Beguinot, F.; D'Esposito, V.; Formisano, P. | |
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma | 1-gen-2022 | Morra, Francesco; Merolla, Francesco; Damia, Giovanna; Ricci, Francesca; Varricchio, Silvia; Ilardi, Gennaro; Arenare, Laura; Califano, Daniela; Napolitano, Virginia; Fruscio, Robert; Melillo, Rosa Marina; Palazzo, Luca; Celetti, Angela | |
AXL is a novel predictive factor and therapeutic target for radioactive iodine refractory thyroid cancer | 1-gen-2019 | Collina, F; La Sala, L; Liotti, F; Prevete, N; La Mantia, E; Chiofalo, Mg; Aquino, G; Arenare, L; Cantile, M; Liguori, G; Di Gennaro, F; Pezzullo, L; Losito, Ns; Vecchio, G; Botti, G; Melillo, Rm; Franco, R | |
Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies | 1-gen-2019 | Liotti, Federica; Prevete, Nella; Vecchio, Giancarlo; Melillo, Rosa Marina | |
New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution | 1-gen-2018 | Prevete, Nella; Prevete, Nella; Liotti, Federica; Amoresano, Angela; Pucci, Piero; de Paulis, Amato; Melillo, ROSA MARINA; Melillo, ROSA MARINA | |
RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2). | 1-gen-2018 | Castellone, Md; Melillo, Rm | |
Role of Formyl Peptide Receptors In Gastrointestinal Healing. | 1-gen-2018 | Prevete, N; de Paulis, A; Sgambato, D; Melillo, Rm; D'Argenio, G; Romano, L; Zagari, Rm; Romano, M | |
Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways | 1-gen-2017 | Prevete, Nella; Liotti, Federica; Illiano, Anna; Amoresano, Angela; Pucci, Piero; de Paulis, Amato; Melillo, Rosa Marina | |
Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells | 1-gen-2017 | Liotti, Federica; Collina, Francesca; Pone, Emanuela; La Sala, Lucia; Franco, Renato; Prevete, Nella; Melillo, ROSA MARINA | |
Multiple anti-tumor effects of Reparixin on thyroid cancer | 1-gen-2017 | Liotti, Federica; De Pizzol, Maria; Allegretti, Marcello; Prevete, Nella; Melillo, Rosa Marina | |
AXL is an oncotarget in human colorectal cancer | 1-gen-2015 | Martinelli, Erika; Martini, Giulia; Cardone, Claudia; Troiani, Teresa; Liguori, Giuseppina; Vitagliano, Donata; Napolitano, Stefania; Morgillo, Floriana; Rinaldi, Barbara; Melillo, ROSA MARINA; Liotti, Federica; Nappi, Anna; Bianco, Roberto; Berrino, Liberato; Ciuffreda Loreta, Pia; Ciardiello, Davide; Iaffaioli, Vincenzo; Botti, Gerardo; Ferraiolo, Fiorella; Ciardiello, Fortunato | |
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth | 1-gen-2015 | Prevete, Nella; Liotti, Federica; Marone, Gianni; Melillo, Rosa Marina; De Paulis, Amato | |
Genetics: The genomic landscape of papillary thyroid carcinoma | 1-gen-2015 | Santoro, Massimo; Melillo Rosa, M | |
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway. | 1-gen-2015 | Visciano, C; Liotti, F; Prevete, N; Cali', G; Franco, R; Collina, F; de Paulis, A; Marone, G; Santoro, M; Melillo, Rm | |
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis | 1-gen-2015 | Prevete, N; Liotti, F; Visciano, C; Marone, G; Melillo, Rm; De Paulis, A | |
The RET receptor family | 1-gen-2015 | Melillo, ROSA MARINA; Santoro, Massimo | |
Indoleamine 2,3-Dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment | 1-gen-2014 | Moretti S.; Menicali E.; Voce P.; Morelli S.; Cantarelli S.; Sponziello M.; Colella R.; Fallarino F.; Orabona C.; Alunno A.; De Biase D.; Bini V.; Mameli M.G.; Filetti S.; Gerli R.; Macchiarulo A.; Melillo R.M.; Tallini G.; Santoro M.; Puccetti P.; Avenia N.; Puxeddu E. |